|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/24 |
| (11) | Patento numeris | 2288382 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09742459.2 |
| Europos patento paraiškos padavimo data | 2009-05-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2009/005796 |
| Data | 2009-05-05 |
| (87) | Numeris | WO 2009/136286 |
| Data | 2009-11-12 |
| (30) | Numeris | Data | Šalis |
| 98369 P | 2008-09-19 | US | |
| 126465 P | 2008-05-05 | US |
| (72) |
MASTERNAK, Krzysztof, CH
LEGER, Olivier, FR
|
| (73) |
NovImmune SA,
14 ch. des Aulx 1228 Plan-Les-Ouates, Geneva,
CH
|
| (54) | ANTI- IL-17A/IL-17F CROSS-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF |
| ANTI- IL-17A/IL-17F CROSS-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF |